Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 28 results matching: "T Miner"
ACE Reports
(28 Reports)
ACE Reports
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
General Orthopaedics
Benzoyl Peroxide vs Standard Prep for Reducing Cutibacterium Acnes in THA
J Arthroplasty. 2025 01-Aug;():. 10.1016/j.arth.2025.04.029
Benzoyl Peroxide vs Standard Prep for Reducing Cutibacterium Acnes in THA
J Arthroplasty. 2025 01-Aug;():. 10.1016/j.arth.2025.04.029
Peri-Operative
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis
J Bone Miner Res. 2023 01-Oct;():. 10.1002/jbmr.4877
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis
J Bone Miner Res. 2023 01-Oct;():. 10.1002/jbmr.4877
Osteoarthritis
Comparing Denosumab Biosimilar GP2411 and Reference Denosumab in Postmenopausal Osteoporosis
J Bone Miner Res. 2024 01-Apr;():. 10.1093/jbmr/zjae016
Comparing Denosumab Biosimilar GP2411 and Reference Denosumab in Postmenopausal Osteoporosis
J Bone Miner Res. 2024 01-Apr;():. 10.1093/jbmr/zjae016
General Orthopaedics
Subcutaneous Abaloparatide in Men with Osteoporosis
J Bone Miner Res. 2022 01-Dec;():. 10.1002/jbmr.4719
Subcutaneous Abaloparatide in Men with Osteoporosis
J Bone Miner Res. 2022 01-Dec;():. 10.1002/jbmr.4719
Osteoarthritis
Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions
J Bone Miner Res. 2022 01-Mar;():. 10.1002/jbmr.4493
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions
J Bone Miner Res. 2022 01-Mar;():. 10.1002/jbmr.4493
General Orthopaedics
No Reduction in Fx Incidence or Mortality with a Fracture Screening Program in At-Risk Elderly Women
J Bone Miner Res. 2019 01-Nov;():. 10.1002/jbmr.3815
No Reduction in Fx Incidence or Mortality with a Fracture Screening Program in At-Risk Elderly Women
J Bone Miner Res. 2019 01-Nov;():. 10.1002/jbmr.3815
Arthroplasty
Denosumab in THA prevents early periprosthetic bone loss, effects diminish after treatment cessation
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2020 ;():. 10.1002/jbmr.3883
Denosumab in THA prevents early periprosthetic bone loss, effects diminish after treatment cessation
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2020 ;():. 10.1002/jbmr.3883
Arthroplasty
AAOS2019: No effect of closed suction IA drain on quad strength and knee joint effusion after TKA
AAOS2019: No effect of closed suction IA drain on quad strength and knee joint effusion after TKA
Metabolic Disorders
Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Metabolic Disorders
The effect of eldecalcitol on balence and strength in women with osteoporosis
J Bone Miner Metab. 2016 Sep;34(5):547-54
The effect of eldecalcitol on balence and strength in women with osteoporosis
J Bone Miner Metab. 2016 Sep;34(5):547-54
Arthroplasty
G-CSF based PBSC transplantation with biomechanical support is safe & effective in ONFH
J Bone Miner Res. 2015 Apr;30(4):647-56
G-CSF based PBSC transplantation with biomechanical support is safe & effective in ONFH
J Bone Miner Res. 2015 Apr;30(4):647-56
Trauma
Fracture risk reduction with multivitamin and mineral supplementation only seen in males
J Bone Miner Metab. 2015 May;33(3):294-302
Fracture risk reduction with multivitamin and mineral supplementation only seen in males
J Bone Miner Metab. 2015 May;33(3):294-302
Arthroplasty
Limited/no tourniquet use beneficial for quadriceps strength vs tourniquet in TKA
Clin Orthop Relat Res. 2016 Jan;474(1):69-77
Limited/no tourniquet use beneficial for quadriceps strength vs tourniquet in TKA
Clin Orthop Relat Res. 2016 Jan;474(1):69-77
Physical Therapy & Rehab
AAOS 2016: High-intensity versus low-intensity rehabilitation following TKA
AAOS 2016: High-intensity versus low-intensity rehabilitation following TKA
Osteoarthritis
Zoledronic acid has no continued benefit beyond 6 years for osteoporosis
J Bone Miner Res. 2015 May;30(5):934-44.
Zoledronic acid has no continued benefit beyond 6 years for osteoporosis
J Bone Miner Res. 2015 May;30(5):934-44.
General Orthopaedics
Bisphosphonates for fracture prevention in osteogenesis imperfecta patients
J Bone Miner Res. 2015 May;30(5):929-33
Bisphosphonates for fracture prevention in osteogenesis imperfecta patients
J Bone Miner Res. 2015 May;30(5):929-33
Metabolic Disorders
Effect of elcatonin in addition to risedronate for women with osteoporosis and back pain
J Bone Miner Metab. 2015 Jul;33(4):432-9
Effect of elcatonin in addition to risedronate for women with osteoporosis and back pain
J Bone Miner Metab. 2015 Jul;33(4):432-9
Metabolic Disorders
Combined & extended alendronate with teriparatide improves BMD in women with osteoporosis
J Bone Miner Res. 2014 Aug;29(8):1777-85
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Combined & extended alendronate with teriparatide improves BMD in women with osteoporosis
J Bone Miner Res. 2014 Aug;29(8):1777-85
Metabolic Disorders
Antiresorptive effects of single zoledronate dose are sustained for 3 years
J Bone Miner Res. 2010 Oct;25(10):2251-5
Antiresorptive effects of single zoledronate dose are sustained for 3 years
J Bone Miner Res. 2010 Oct;25(10):2251-5
Spine
Vertebroplasty for osteoporotic fractures yield no benefit over placebo at 2-years
J Bone Miner Res. 2014 Jun;29(6):1346-55.
Vertebroplasty for osteoporotic fractures yield no benefit over placebo at 2-years
J Bone Miner Res. 2014 Jun;29(6):1346-55.
Showing 1-20 of 28 results
1
2